Provided by Tiger Trade Technology Pte. Ltd.

Novavax

7.70
-0.3200-3.99%
Pre-market: 7.890.1921+2.49%07:21 EDT
Volume:4.66M
Turnover:35.81M
Market Cap:1.25B
PE:2.98
High:7.91
Open:7.70
Low:7.57
Close:8.02
52wk High:11.97
52wk Low:5.01
Shares:162.50M
Float Shares:136.72M
Volume Ratio:1.17
T/O Rate:3.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.58
EPS(LYR):2.58
ROE:-898.20%
ROA:25.72%
PB:-9.79
PE(LYR):2.98

Loading ...

Novavax Inc. Stock Falls 6.1%, Underperforms Peers

Dow Jones
·
Mar 04

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Feb 28

Novavax price target raised to $8 from $7 at BofA

TIPRANKS
·
Feb 27

Novavax Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 27

Novavax price target raised to $16 from $11 at H.C. Wainwright

TIPRANKS
·
Feb 27

Novavax, Inc. : H.c. Wainwright Raises Target Price to $16 From $11

THOMSON REUTERS
·
Feb 27

Novavax Inc. Stock Rises 17.4%, Outperforms Peers

Dow Jones
·
Feb 27

Top Midday Gainers

MT Newswires Live
·
Feb 27

Novavax Shares Surge on Surprise Swing to 4Q Profit

Dow Jones
·
Feb 27

Novavax Rockets 19% as It Raises 2026 Adjusted Revenue Outlook on Strength in Vaccine Deals

Reuters
·
Feb 26

Novavax Shares up 6% After Raising 2026 Adjusted Revenue Outlook

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Co Expects Royalties to Grow Significantly in the 2026-'27 Season Compared to 2025

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Co Sees a Pathway Forward and Ability to Negotiate and Work With the Current Administration

THOMSON REUTERS
·
Feb 26

Novavax CEO Says Current Macro and Regulatory Environment in the United States Pose Significant Uncertainties for Vaccine Companies -Conf Call

THOMSON REUTERS
·
Feb 26

Novavax Exec Says Encouraged by Moderna's Progress With Their Flu Vaccine

THOMSON REUTERS
·
Feb 26

Novavax CEO on Upcoming Cdc Acip- "There's a Meeting NOW on the Books, so That's Good and We'LL Pay Attention to That"

THOMSON REUTERS
·
Feb 26

Novavax Shares Rise 1.8% Premarket After Raising 2026 Revenue Forecast

THOMSON REUTERS
·
Feb 26

Stock Track | Novavax Plunges 8.71% in Pre-Market as 2026 Revenue Guidance Falls Short of Analyst Expectations

Stock Track
·
Feb 26

Novavax Q4 EPS $0.11, Sales $147.139M

Benzinga
·
Feb 26

Earnings Flash (NVAX) Novavax Posts Q4 EPS $0.11, vs. FactSet Est of $0.48 Loss

MT Newswires Live
·
Feb 26